Lei Wang

Dr. Lei Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2024 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
QLQing Liu
Qing Liu
ZLZiyu Liu
Ziyu Liu
WXWenmeng Xie
Wenmeng Xie
YLYibo Li
Yibo Li
HWHongfang Wang
Hongfang Wang
LWLei Wang
Lei Wang
Background: N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin widely used to induce PD models, but the effect of MPTP on the cells and genes of PD has not been fully elucidated.Methods: Single-nucleus RNA sequencing was performed in the Substantia Nigra (SN) of MPTP mice. UMAP analysis was used for the dimensionality reduction visualization of the SN in the MPTP mice. Known marker genes highly expressed genes in each cluster were used to annotate most clusters. Specific Differentially Expressed Genes (DEGs) and PD risk genes analysis were used to find MPTP-associated cells. GO, KEGG, PPI network, GSEA and CellChat analysis were used to reveal cell type-specific functional alterations and disruption of cell-cell communication networks. Subset reconstruction and pseudotime analysis were used to reveal the activation status of the cells, and to find the transcription factors with trajectory characterized.Results: Initially, we observed specific DEGs and PD risk genes enrichment in microglia. Next, We obtained the functional phenotype changes in microglia and found that IGF, AGRN and PTN pathways were reduced in MPTP mice. Finally, we analyzed the activation state of microglia and revealed a pro-inflammatory trajectory characterized by transcription factors Nfe2l2 and Runx1.Conclusion: Our work revealed alterations in microglia function, signaling pathways and key genes in the SN of MPTP mice.

26 February 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
HWHui Wang
Hui Wang
LQLi-Li Qi
Li-Li Qi
CSClement Shema
Clement Shema
KJKui-Ying Jiang
Kui-Ying Jiang
PRPing Ren
Ping Ren
LWLei Wang
Lei Wang
With the development of social population ageing, bone fracture has become a global public health problem due to its high morbidity, disability and mortality. Fracture healing is a complex phenomenon involving the coordinated participation of immigration, differentiation and proliferation of inflammatory cells, angioblasts, fibroblasts, chondroblasts and osteoblasts which synthesize and release bioactive substances of extracellular matrix components, Mortality caused by age-related bone fractures or osteoporosis is steadily increasing worldwide as the population ages. Fibroblasts play an important role in the process of fracture healing. However, it is not clear how the growth factors and extracellular matrix stiffness of the bone-regeneration microenvironment affects the function of osteoblasts and fibroblasts in healing process. Therefore, this article focuses on the role of fibroblasts in the process of fracture healing and mechanisms of research progress.

25 July 2025 in Cells
Verified
Journal Article
Open access
PDF file
YLYibo Li
Yibo Li
ZSZhaowen Su
Zhaowen Su
纪翟纪彤 翟
纪彤 翟
QLQing Liu
Qing Liu
HWHongfang Wang
Hongfang Wang
LWLei Wang
Lei Wang
Background: Parkinson’s disease (PD) involves progressive dopaminergic neuron degeneration and motor deficits. Oligodendrocyte dysfunction contributes to PD pathogenesis through impaired myelination. Methods: Single-nucleus RNA sequencing (snRNA-seq) of PD mice revealed compromised oligodendrocyte differentiation and STAT5B downregulation. Pseudotemporal trajectory analysis via Monocle2 demonstrated impaired oligodendrocyte maturation in PD oligodendrocytes, correlating with reduced myelin-related gene expression (Sox10, Plp1, Mbp, Mog, Mag, Mobp). DoRothEA-predicted regulon activity identified STAT5B as a key transcriptional regulator. Results: Oligodendrocyte-specific STAT5B activation improved myelin integrity, as validated by Luxol Fast Blue staining and transmission electron microscopy; attenuated dopaminergic neuron loss; and improved motor function. Mechanistically, STAT5B binds the MBP promoter to drive transcription, a finding confirmed by the luciferase assay, while the DNMT3A-mediated hypermethylation of the STAT5B promoter epigenetically silences its expression, as verified by MethylTarget sequencing and methylation-specific PCR. Conclusions: DNMT3A inhibited the expression of STAT5B by affecting its methylation, which reduced the transcription of MBP, caused oligodendrocyte myelin damage, and eventually led to dopamine neuron damage and motor dysfunction in an MPTP-induced mouse model. This DNMT3A-STAT5B-MBP axis underlies PD-associated myelin damage, connecting epigenetic dysregulation with oligodendrocyte dysfunction and subsequent PD pathogenesis.

10 November 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YLYibo Li
Yibo Li
JHJiaxin Hao
Jiaxin Hao
WWWenyu Wang
Wenyu Wang
ZSZhaowen Su
Zhaowen Su
XTXiaofeng Tian
Xiaofeng Tian
LWLei Wang
Lei Wang
Parkinson’s disease (PD) is clinically characterized by motor dysfunction, and its pathology primarily involves the progressive loss of dopaminergic neurons. Despite extensive research, the precise etiological mechanisms remain elusive. Recent findings have revealed a significant role of astrocytes in PD onset and progression. However, fully elucidating their function has been challenging because of the heterogeneity of cells and the complexity of the disease progression. Here, we successfully used single-nuclear RNA sequencing to characterize diverse genes expressed by astrocytes and analyzed changes in biological processes in a PD mouse model. Pseudotime analysis (Monocle2) indicated that as PD progressed the status of astrocytes transitioned from immune activation states to neurotoxic subtypes, which correlates with marked upregulation of inflammation-related genes, including Nlrp3 and IL-1β. Furthermore, CellChat analysis demonstrated that BMP signaling exhibited significant specificity in PD, with Bmp6 as the primary ligand and astrocytes as crucial mediators and responders. Thus, we demonstrated that BMP signaling activation in astrocytes exacerbates dopamine neuronal death. Rather, inhibiting BMP signaling in astrocytes significantly improved motor dysfunction and reduced the loss of dopamine neurons in a PD mouse model. Mechanistically, we found that activation of the BMP signaling pathway promoted the release of Nlrp3, IL-1β, and TNF-α, suggesting that increased neuroinflammation aggravated dopaminergic neuronal death. Together, these findings highlight the crucial role of astrocytes in the pathogenesis of PD and reveal a novel cellular mechanism that offers potential therapeutic targets for PD intervention.

25 March 2024 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
HWHong-Fang Wang
Hong-Fang Wang
YLYi-Bo Li
Yi-Bo Li
ZLZi-Yu Liu
Zi-Yu Liu
WXWen-Meng Xie
Wen-Meng Xie
QLQing Liu
Qing Liu
DGDan Dan Geng
Dan Dan Geng

16 July 2026 in Molecular Neurobiology
Verified
Journal Article
Closed access
XTXiaofeng Tian
Xiaofeng Tian
QLQing Liu
Qing Liu
JZJiacheng Zhang
Jiacheng Zhang
HDHuijiao Du
Huijiao Du
ZWZhaoran Wei
Zhaoran Wei
YZYizhou Zhang
Yizhou Zhang